MRI-Guided Focused Ultrasound as a New Method of Drug Delivery. (12th May 2013)

• Record Type: Journal Article
• Authors: Thanou, M.; Gedroyc, W.
• Other Names: Tzakos Andreas G. Academic Editor.
• Is Part Of: Journal of drug delivery. Volume 2013(2013)
• Publication Date: 2013-05-12
• Subjects: Drug delivery systems -- Periodicals; 615.605
• DOI: 10.1155/2013/616197
• Languages: English
• ISSNs: 2090-3014

Abstract

Abstract : Ultrasound-mediated drug delivery under the guidance of an imaging modality can improve drug disposition and achieve site-specific drug delivery. The term focal drug delivery has been introduced to describe the focal targeting of drugs in tissues with the help of imaging and focused ultrasound. Focal drug delivery aims to improve the therapeutic profile of drugs by improving their specificity and their permeation in defined areas. Focused-ultrasound- (FUS-) mediated drug delivery has been applied with various molecules to improve their local distribution in tissues. FUS is applied with the aid of microbubbles to enhance the permeability of bioactive molecules across BBB and improve drug distribution in the brain. Recently, FUS has been utilised in combination with MRI-labelled liposomes that respond to temperature increase. This strategy aims to "activate" nanoparticles to release their cargo locally when triggered by hyperthermia induced by FUS. MRI-guided FUS drug delivery provides the opportunity to improve drug bioavailability locally and therefore improve the therapeutic profiles of drugs. This drug delivery strategy can be directly translated to clinic as MRg FUS is a promising clinically therapeutic approach. However, more basic research is required to understand the physiological mechanism of FUS-enhanced drug delivery.